Evidence map›Paper›PMID 25309426›Full record

ReviewFrontiers in aging neuroscience2014

Alzheimer's disease and the fornix.

Kenichi Oishi, Constantine G Lyketsos

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in aging neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Review
  10. The fornix supports episodic memory during childhood.Cerebral cortex (New York, N.Y. : 1991) · 2022
    Article
  11. Article
  12. Article
  13. Disconnection Syndromes.Noro psikiyatri arsivi · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. White matter microstructure disruption in early stage amyloid pathology.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kenichi OishiThe Russell H. Morgan Department of Radiology and Radiological Science, School of Medicine, Johns Hopkins University Baltimore, MD, USA.
Constantine G LyketsosDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins Bayview and Johns Hopkins Medicine Baltimore, MD, USA.
Johns Hopkins University · US

Funding

'T V ASSESSMENT - MEMORY DISORDERED PATIENTS'P50AG005146 · NIA · JOHNS HOPKINS UNIVERSITY · PI HUGANIR, RICHARD L · 1985 to 2019
$37.6M
Citalopram Treatment for Agitation in Alzheimer DementiaR01AG031348 · NIA · JOHNS HOPKINS UNIVERSITY · PI LYKETSOS, CONSTANTINE G · 2008 to 2012
$7.9M
Exploring the relationship between cerebral glucose metabolism and change in cognition in the ADvance randomized control trial of Deep Brain StimulationR01AG042165 · NIA · JOHNS HOPKINS UNIVERSITY · PI LOZANO, ANDRES M., LYKETSOS, CONSTANTINE G · 2012 to 2016
$2.8M
Development of quantitative MRI DTI analysis tool for preterm neonateR01HD065955 · NICHD · JOHNS HOPKINS UNIVERSITY · PI OISHI, KENICHI · 2011 to 2015
$2.3M
Longitudinal and Cross-sectional White Matter Analysis of Alzheimer's DiseaseR21AG033774 · NIA · JOHNS HOPKINS UNIVERSITY · PI OISHI, KENICHI · 2009 to 2010
$336k
NIA NIH HHS P50 AG005146NIA NIH HHS R01 AG031348NIA NIH HHS R01 AG042165NIA NIH HHS R21 AG033774NICHD NIH HHS R01 HD065955
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common form of neurodegenerative dementia. Researchers have long been focused on the cortical pathology of AD, since the most important pathologic features are the senile plaques found in the cortex, and the neurofibrillary tangles and neuronal loss that begin in the entorhinal cortex and the hippocampus. In addition to these gray matter (GM) structures, histopathological studies indicate that the white matter (WM) is also a good target for both the early diagnosis of AD and for monitoring disease progression. The fornix is a WM bundle that constitutes a core element of the limbic circuits, and is one of the most important anatomical structures related to memory. Functional and anatomical features of the fornix have naturally captured researchers' attention as possible diagnostic and prognostic markers of AD. Indeed, neurodegeneration of the fornix has been histologically observed in AD, and growing evidence indicates that the alterations seen in the fornix are potentially a good marker to predict future conversion from mild cognitive impairment (MCI) to AD, and even from cognitively normal individuals to AD. The degree of alteration is correlated with the degree of memory impairment, indicating the potential for the use of the fornix as a functional marker. Moreover, there have been attempts to stimulate the fornix using deep brain stimulation (DBS) to augment cognitive function in AD, and ongoing research has suggested positive effects of DBS on brain glucose metabolism in AD patients. On the other hand, disease specificity for fornix degeneration, methodologies to evaluate fornix degeneration, and the clinical significance of the fornix DBS, especially for the long-term impact on the quality of life, are mostly unknown and need to be elucidated.

Indexed as

Alzheimer’s diseasedeep brain stimulationdiffusion tensor imagingfornixlimbic systemmagnetic resonance imagingmild cognitive impairmentwhite matter

Identifiers

PMID25309426
PMCPMC4161001
OpenAlexW1995699752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.